Imaging: Red light warning sign for clear-cell renal cell carcinoma—REDECT reveals imaging biomarker

  • Rebecca Kirk
  • Published 2013 in Nature Reviews Clinical Oncology

Abstract

Red light warning sign for clear-cell renal cell carcinoma—REDECT reveals imaging biomarker The ability to differentiate between indolent or benign renal cell tumours and the aggressive clearcell renal cell carcinoma (ccRCC) before surgical resection is important in clinical decision making. In terms of treatment options—and requirements—the type of tumour being treated is crucial. For example, for patients with tumours that have replaced the entire kidney, radical nephrectomy would be the optimal treatment choice; however, for patients with a small renal mass it is possible to perform nephron-sparing surgery, which can avoid some of the adverse effects associated with radical nephrectomy. Now, the possibility has been raised that a novel imaging biomarker could be used to guide these treatment choices, and thereby optimize therapy and surgical options.

DOI: 10.1038/nrclinonc.2012.232

Cite this paper

@article{Kirk2013ImagingRL, title={Imaging: Red light warning sign for clear-cell renal cell carcinoma—REDECT reveals imaging biomarker}, author={Rebecca Kirk}, journal={Nature Reviews Clinical Oncology}, year={2013}, volume={10}, pages={63-63} }